Keith Yamamoto is vice chancellor for science policy and strategy, director of precision medicine, and emeritus professor of cellular & molecular pharmacology at UCSF. After earning a PhD from Princeton, Yamamoto joined the UCSF faculty in 1976, where he pursued signaling and transcriptional regulatory mechanisms and networks. He has led or served on national committees focused on public and science policy, public understanding/support of scientific research, science education and the biomedical workforce, research funding, peer review, and diversity, equity, inclusion and anti-racism. He is President of the American Association for the Advancement of Science (AAAS), chair of the Coalition for the Life Sciences, co-chair of the NASEM Roundtable on Aligning Incentives for Open Science and of the Science and Technology Action Committee, vice chair of the California Initiative to Advance Precision Medicine Advisory Council. He sits on the Boards of Directors of the Public Library of Science, Research!America and Rapid Science, the Governing Board of the California Institute for Regenerative Medicine, the Board of Counselors for the Radiation Effects Research Foundation, the Advisory Board for Lawrence Berkeley National Laboratory, and the Council of the Engineering Biology Research Consortium. He was elected to the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Academy of Microbiology, and is a fellow of AAAS.